Literature DB >> 7460390

Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood.

I O Auer, E Ziemer, H Sommer.   

Abstract

To identify and measure the spontaneous cell-mediated cytotoxicity of natural killer cells, we used the lysis of an established lymphoblastoid cell line as target in a 4-hr 51Cr-release assay. Mononuclear cell suspensions of the peripheral blood of thirty-four patients with Crohn's disease (group CD), eleven patients with inflammatory bowel disease other than CD or ulcerative colitis (group D) and forty-five healthy subjects matched for both age and sex with the patients were studied. Depletion of phagocytic, plastic-adherent cells ('purified suspensions') led to a significant increase of the natural killer cell activity as compared with unseparated suspensions. This was seen to occur in all groups. In CD patients the natural killer cell activity was significantly below normal levels in both unseparated and 'purified' suspensions. This was independent of disease duration. In 'purified' suspensions the natural killer cell activity was inversely related to the disease activity. In group D the natural cytotoxicity was significantly lower in unseparated suspensions than that in healthy controls. In 'purified' suspensions it was still slightly lower than in healthy controls.

Entities:  

Mesh:

Year:  1980        PMID: 7460390      PMCID: PMC1537072     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells,.

Authors:  J E de Vries; S Cornain; P Rumke
Journal:  Int J Cancer       Date:  1974-10-15       Impact factor: 7.396

2.  Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A.

Authors:  G Trinchieri; M De Marchi; W Mayr; M Savi; R Ceppellini
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Antibody-dependent lymphocyte-mediated cytotoxicity in an allogeneic human system. II. Evidence for HL-A specificity.

Authors:  E Dickmeiss; L S Nielsen
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

5.  Reactivity of lymphocytes from normal persons on cultured tumor cells.

Authors:  M Takasugi; M R Mickey; P I Terasaki
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

6.  Crohn's disease and cancer.

Authors:  D D Weedon; R G Shorter; D M Ilstrup; K A Huizenga; W F Taylor
Journal:  N Engl J Med       Date:  1973-11-22       Impact factor: 91.245

7.  Malignancy in Crohn's disease.

Authors:  J F Fielding; P Prior; J A Waterhouse; W T Cooke
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

8.  Specificity of cell-mediated cytotoxicity against human melanoma lines: evidence for "non-specific" killing by activated T-cells.

Authors:  P Hersey; A Edwards; J Edwards; E Adams; G W Milton; D S Nelson
Journal:  Int J Cancer       Date:  1975-07-15       Impact factor: 7.396

9.  Lysis of leukemia cells by spleen cells of normal mice.

Authors:  J M Zarling; R C Nowinski; F H Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

10.  Studies of the human lymphocyte receptor for heat-aggregated or antigen-complexed immunoglobulin.

Authors:  H B Dickler
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

View more
  23 in total

Review 1.  The role of NK cells in the autoimmune thyroid disease-associated pregnancy loss.

Authors:  Emiliana Konova
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

2.  Enhanced peripheral blood T-cell cytotoxicity in inflammatory bowel disease.

Authors:  F Shanahan; B Leman; R Deem; A Niederlehner; M Brogan; S Targan
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

3.  Effects of nutritional therapy on chemiluminescence in Crohn's disease.

Authors:  N Okabe; K Maeda; M Okada; M Ueki; T Sakurai; T Matsui; T Yao
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

4.  Inhibition of cell mediated cytotoxicity by sulphasalazine: effect of in vivo treatment with 5-aminosalicylic acid and sulphasalazine on in vitro natural killer cell activity.

Authors:  M N Aparicio-Pagés; H W Verspaget; J C Hafkenscheid; G E Crama-Bohbouth; A S Peña; I T Weterman; H W Lamers
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

5.  Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients.

Authors:  R Giacomelli; A Passacantando; G Frieri; I Parzanese; S D'Alò; P Vernia; M T Pimpo; C Petrucci; R Caprilli; M G Cifone; G Tonietti
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

6.  Peripheral blood lymphocytes from thermal injury patients are defective in their ability to generate lymphokine-activated killer (LAK) cell activity.

Authors:  G R Klimpel; D H Herndon; M D Stein
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

7.  Biotin effects in Crohn's disease.

Authors:  N Okabe; K Urabe; K Fujita; T Yamamoto; T Yao; S Doi
Journal:  Dig Dis Sci       Date:  1988-11       Impact factor: 3.199

8.  Immunological studies on Crohn's disease. V. Enumeration of circulating lymphocytes subsets using monoclonal antibodies.

Authors:  N Okabe; K Fujita; M Yamasaki; T Yao; S Tsuru
Journal:  Gastroenterol Jpn       Date:  1985-10

9.  Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes.

Authors:  K Negishi; N Waldeck; G Chandy; B Buckingham; A Kershnar; L Fisher; S Gupta; M A Charles
Journal:  Diabetologia       Date:  1986-06       Impact factor: 10.122

10.  Cefodizime stimulates subpopulations of cells mediating spontaneous or antibody-dependent cytotoxicity in patients with bacterial infections.

Authors:  I O Auer; C Hardörfer; I Zimmermann
Journal:  Infection       Date:  1992       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.